185 related articles for article (PubMed ID: 32640108)
1. Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
Wang S; Wang XL; Wu ZZ; Yang QC; Xiong HG; Xiao Y; Li H; Sun ZJ
Oral Dis; 2021 Mar; 27(2):204-214. PubMed ID: 32640108
[TBL] [Abstract][Full Text] [Related]
2. Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma.
Iwamoto K; Nakashiro K; Tanaka H; Tokuzen N; Hamakawa H
Int J Oncol; 2015 May; 46(5):1971-7. PubMed ID: 25738429
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J
Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664
[TBL] [Abstract][Full Text] [Related]
5. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
Rahman MA; Amin AR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG; Shin DM
Clin Cancer Res; 2013 Jul; 19(13):3416-28. PubMed ID: 23719266
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
[TBL] [Abstract][Full Text] [Related]
7. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
8. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.
He KF; Zhang L; Huang CF; Ma SR; Wang YF; Wang WM; Zhao ZL; Liu B; Zhao YF; Zhang WF; Sun ZJ
Biomed Res Int; 2014; 2014():838632. PubMed ID: 24883329
[TBL] [Abstract][Full Text] [Related]
9. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
10. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
11. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
12. The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma.
Lin CM; Lin LW; Chen TC; Ye YL; Chiang BL
Cancer Med; 2023 Sep; 12(18):18918-18930. PubMed ID: 37654227
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
Zhu SW; Wang S; Wu ZZ; Yang QC; Chen DR; Wan SC; Sun ZJ
Oral Dis; 2022 Mar; 28(2):364-372. PubMed ID: 33386685
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
15. High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.
Lee B; Ha SY; Song DH; Lee HW; Cho SY; Park CK
Gut Liver; 2014 Nov; 8(6):662-8. PubMed ID: 25368754
[TBL] [Abstract][Full Text] [Related]
16. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of cancer stem cell subpopulations in oral squamous cell carcinoma.
Amôr NG; Buzo RF; Ortiz RC; Lopes NM; Saito LM; Mackenzie IC; Rodini CO
J Oral Pathol Med; 2021 Jan; 50(1):52-59. PubMed ID: 32816395
[TBL] [Abstract][Full Text] [Related]
18. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
[TBL] [Abstract][Full Text] [Related]
20. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]